申请人:Ohmeda Pharmaceutical Products Division Inc.
公开号:EP0277794A2
公开(公告)日:1988-08-10
Compounds of the formula
have analgesic or antagonist properties. In the formula:
R is a saturated or unsaturated heterocyclic ring system of from 4 to 10 carbon atoms, including 1 to 3 nitrogen atoms, and 0 to 1 sulphur or oxygen atoms; R¹ is a furanyl, thienyl or lower alkyl lower alkoxy group; and R² is a phenyl lower alkyl group. The heterocyclic ring may be unsubstituted or substituted by a halogen or by a lower alkyl, lower alkoxy, halogenated lower alkyl, or lower alkylthio group, or combinations thereof.
式中的化合物
具有镇痛或拮抗特性。式中
R 是由 4 至 10 个碳原子(包括 1 至 3 个氮原子)和 0 至 1 个硫或氧原子组成的饱和或不饱和杂环系统;R¹ 是呋喃基、噻吩基或低级烷基低级烷氧基;R² 是苯基低级烷基。杂环可以是未取代的,也可以被卤素或低级烷基、低级烷氧基、卤代低级烷基或低级烷硫基或它们的组合取代。